Abstract:
Advances in asthma management, particularly the introduction
of controller medication of which inhaled corticosteroids are
the most important, has resulted in a steady decline in asthma
mortality in most countries. This is usually accompanied
by a decline in episodes of near-fatal asthma attacks and
hospitalisations, and a reduction in other indicators of asthma
morbidity. These gains have led to a shift in thinking on
the management of asthma, away from simply preventing
death and hospitalisations, toward achieving and maintaining
sustained control of all clinical features.
